Form 4 for TIL Instil Bio, Inc.
Accepted 2025-09-12 00:00:00 ET · period of report 2025-09-10 · accession 0001789769-25-000087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-09-12 | 2025-09-10 | TIL | Laumas Sandeep | CFO, CBO | M - OptEx | $12.07 | +30.0K | 30.0K | New | +$362.0K |
| DM | 2025-09-12 | 2025-09-10 | TIL | Laumas Sandeep | CFO, CBO | S - Sale+OE | $23.39 | -30.0K | 12.5K | -71% | -$701.7K |
| DM | 2025-09-12 | 2025-09-10 | TIL | Laumas Sandeep | CFO, CBO | M - OptEx | $0.00 | -30.0K | 17.0K | -64% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-10 | M | A | 17,000 | $11.60 | 17,000 | D | — | — | |
| 2 | Common | Common Stock | 2025-09-10 | M | A | 13,000 | $12.68 | 30,000 | D | — | — | |
| 3 | Common | Common Stock | 2025-09-10 | S | D | 12,461 | $23.88 | 0 | D | — | — | (F2) The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $23.71 to $24.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2). |
| 4 | Common | Common Stock | 2025-09-10 | S | D | 17,539 | $23.04 | 12,461 | D | — | — | (F1) The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $22.70 to $23.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). |
| 5 | Derivative | Employee Stock Option (right to buy) | 2025-09-10 | M | D | 13,000 | $0.00 | 30,000 | D | $12.68 · — to 2033-01-07 | 13,000 Common Stock | (F4) Stock option granted under the Instil Bio, Inc. 2021 Incentive Plan. 25% of the shares subject to the option vested on January 8, 2024 with the remainder vesting in substantially equal monthly tranches thereafter. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2025-09-10 | M | D | 17,000 | $0.00 | 17,000 | D | $11.60 · — to 2034-02-09 | 17,000 Common Stock | (F3) Stock option granted under the Instil Bio, Inc. 2021 Incentive Plan. 25% of the shares subject to the option vested on February 10, 2025 with the remainder vesting in substantially equal monthly tranches thereafter. |